Abstract
Perthiolated β-cyclodextrin-based nanocapsules incorporating diaquo Gd(III)-complexes represent a promising new type of bioresponsive MRI contrast agent, showing a pronounced relaxivity change upon degradation in a reducing environment.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have